Literature DB >> 18424327

Immunisation against poliomyelitis: moving forward.

Ellie Ehrenfeld1, Roger I Glass, Vadim I Agol, Konstantin Chumakov, Walter Dowdle, T Jacob John, Samuel L Katz, Mark Miller, Joel G Breman, John Modlin, Peter Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18424327     DOI： 10.1016/S0140-6736(08)60597-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance.

Authors:  Maria L Yakovenko; Ekaterina A Korotkova; Olga E Ivanova; Tatyana P Eremeeva; Elena Samoilovich; Iryna Uhova; Gene V Gavrilin; Vadim I Agol
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

2.  Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.

Authors:  Zhaochun Chen; Konstantin Chumakov; Eugenia Dragunsky; Diana Kouiavskaia; Michelle Makiya; Alexander Neverov; Gennady Rezapkin; Andrew Sebrell; Robert Purcell
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

3.  Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishments.

Authors:  Joel G Breman; Kenneth Bridbord; Linda E Kupfer; Roger I Glass
Journal:  Infect Dis Clin North Am       Date:  2011-09       Impact factor: 5.982

Review 4.  New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.

Authors:  Konstantin Chumakov; Ellie Ehrenfeld
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

5.  Effect of formaldehyde inactivation on poliovirus.

Authors:  Thomas Wilton; Glynis Dunn; David Eastwood; Philip D Minor; Javier Martin
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

Review 6.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

7.  Antiviral activity of 3(2H)- and 6-chloro-3(2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolates.

Authors:  Lester M Shulman; Danit Sofer; Yossi Manor; Ella Mendelson; Jean Balanant; Anna Laura Salvati; Francis Delpeyroux; Lucia Fiore
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

Review 8.  Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.

Authors:  Thomas R Hird; Nicholas C Grassly
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.